Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation
Karen M. Dwyer(The Royal Melbourne Hospital), Anthony J.F. d’Apice(St Vincent's Hospital Melbourne), Harshal Nandurkar(St Vincent's Hospital Melbourne), Elżbieta Kaczmarek(Poznan University of Medical Sciences), Duncan J. Campbell(St. Vincent's Birmingham), Simon C. Robson(Beth Israel Deaconess Medical Center), Nella Fisicaro(St Vincent's Hospital Melbourne), Peter J. Cowan(St Vincent's Hospital Melbourne), Tharun B. Mysore(St Vincent's Hospital Melbourne), Lisa J. Murray-Segal(St Vincent's Hospital Melbourne), Hilton Gock(St Vincent's Hospital Melbourne)
Cited by 183
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928
The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
|Immunological Reviews|2017|901
Purinergic Signaling during Inflammation
|New England Journal of Medicine|2012|703